Matches in Wikidata for { <http://www.wikidata.org/entity/Q92168127> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q92168127 description "2019 թվականի մարտի 12-ին հրատարակված գիտական հոդված" @default.
- Q92168127 description "article scientifique publié en 2019" @default.
- Q92168127 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92168127 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92168127 description "scientific article published on 12 March 2019" @default.
- Q92168127 description "wetenschappelijk artikel" @default.
- Q92168127 description "наукова стаття, опублікована 12 березня 2019" @default.
- Q92168127 name "Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)" @default.
- Q92168127 name "Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)" @default.
- Q92168127 type Item @default.
- Q92168127 label "Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)" @default.
- Q92168127 label "Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)" @default.
- Q92168127 prefLabel "Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)" @default.
- Q92168127 prefLabel "Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)" @default.
- Q92168127 P1433 Q92168127-EB5CAC96-BD2B-406B-8BFD-37FF70B3AE43 @default.
- Q92168127 P1476 Q92168127-8C0187A1-4491-430F-99CA-4B9FB2880B13 @default.
- Q92168127 P2093 Q92168127-100125BD-3CAA-43B7-BC01-31CA32F8DD67 @default.
- Q92168127 P2093 Q92168127-11EC2C7F-F11E-4818-B8E5-850BC746CDE3 @default.
- Q92168127 P2093 Q92168127-232BF5BC-0337-43E2-B37D-C8B44B14C762 @default.
- Q92168127 P2093 Q92168127-2A6CF42F-A4B0-40B0-92F6-E170D3DCBBDE @default.
- Q92168127 P2093 Q92168127-35A22A80-4CD6-4776-BD54-2E9BA3ECBD1F @default.
- Q92168127 P2093 Q92168127-390211D0-2C87-4AD4-BECB-CE9535039851 @default.
- Q92168127 P2093 Q92168127-46A6E402-DF01-49FA-B3D0-6E6AC38D7654 @default.
- Q92168127 P2093 Q92168127-6C1165E1-BDD3-4AB6-B3DB-9D97BE9AE38C @default.
- Q92168127 P2093 Q92168127-D14A9ADA-256D-439F-B720-48FFF07708AB @default.
- Q92168127 P2093 Q92168127-DAD4699B-03E3-4523-B128-A36AAA8EA15F @default.
- Q92168127 P2093 Q92168127-FD64A37A-7F18-4B1E-B919-4697510E4430 @default.
- Q92168127 P304 Q92168127-062855D3-D716-486D-8D61-5ACA661DD764 @default.
- Q92168127 P31 Q92168127-A9AC7705-3BB1-47A3-93D3-18C063D61640 @default.
- Q92168127 P356 Q92168127-A61CC43E-A453-4B5C-B6BE-2B058F2757BD @default.
- Q92168127 P433 Q92168127-D5A71357-BF9A-4259-90F2-10D74B2F0977 @default.
- Q92168127 P478 Q92168127-8C9A3946-7957-45FF-BB82-392B75221D97 @default.
- Q92168127 P577 Q92168127-B38514A1-6863-46ED-8E65-36BA1DA0615E @default.
- Q92168127 P698 Q92168127-4B91876C-97F1-475B-89C4-AE6941638E2E @default.
- Q92168127 P921 Q92168127-6E56D576-5C1C-46A6-857A-981803AEB21E @default.
- Q92168127 P921 Q92168127-7221C1B6-2C1A-4980-8C36-09359F2667FF @default.
- Q92168127 P356 J.JDERMSCI.2019.02.002 @default.
- Q92168127 P698 31109652 @default.
- Q92168127 P1433 Q15749351 @default.
- Q92168127 P1476 "Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)" @default.
- Q92168127 P2093 "Abhijit Gadkari" @default.
- Q92168127 P2093 "Bolanle Akinlade" @default.
- Q92168127 P2093 "Diamant Thaçi" @default.
- Q92168127 P2093 "Eric L Simpson" @default.
- Q92168127 P2093 "Gianluca Pirozzi" @default.
- Q92168127 P2093 "Laurent Eckert" @default.
- Q92168127 P2093 "Marius Ardeleanu" @default.
- Q92168127 P2093 "Mette Deleuran" @default.
- Q92168127 P2093 "Neil M H Graham" @default.
- Q92168127 P2093 "Yoko Kataoka" @default.
- Q92168127 P2093 "Zhen Chen" @default.
- Q92168127 P304 "266-275" @default.
- Q92168127 P31 Q13442814 @default.
- Q92168127 P356 "10.1016/J.JDERMSCI.2019.02.002" @default.
- Q92168127 P433 "2" @default.
- Q92168127 P478 "94" @default.
- Q92168127 P577 "2019-03-12T00:00:00Z" @default.
- Q92168127 P698 "31109652" @default.
- Q92168127 P921 Q268667 @default.
- Q92168127 P921 Q42824827 @default.